🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Lipe & Dalton - Q2 2026 13F Filings

LI

Lipe & Dalton

CIK: 0001570396
Address: New York Syracuse 103 East Water Street Suite 305
$215.13 M
Portfolio Value
94
Assets Held
Reporting Period: Q2 2026
Filing Status:
Active
Last Updated: 10/14/2026

Portfolio Summary (Q2 2026)

View Full Portfolio Analysis

Top Buys

Q2 2026

Top Sells

Q2 2026

Asset Allocation

Stocks/ETFs
+10.54%
$208.67 M 97.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
+186.30%
$6.46 M 3.00%

Sector Allocation (Stocks)

Lipe & Dalton Q2 2026 Filing Summary

Lipe & Dalton filed its 13F report for Q2 2026 on July 14, 2026. The portfolio totaled 215.13 M reflecting a +12.61% change from the prior quarter, spanning 94 assets. The top 10 holdings comprised 46.5% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 7 new positions and 5 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Lipe & Dalton’s Q2 2026 Filing

Lipe & Dalton submitted their Form 13F-HR for the Q2 2026 period on 07/14/2026. This was the only submission for the quarter.

In the Q2 2026 filing, Lipe & Dalton reported a managed portfolio value of 215.13 M, consisting of 94 individual positions.

This page displays the raw filing documents. To see which stocks Lipe & Dalton bought or sold during Q2 2026, please visit Lipe & Dalton's Portfolio Analysis page.